Gastrointestinal Stromal Tumor (GIST) Market is driven by targeted...

adicionou um novo artigo Health

2025-06-16 10:08:10 -

Gastrointestinal Stromal Tumor (GIST) Market is driven by targeted therapies

The gastrointestinal stromal tumor (GIST) market encompasses a range of targeted therapies, small-molecule inhibitors, monoclonal antibodies, and companion diagnostics designed to manage and treat GIST, a rare form of soft tissue tumor arising in the digestive tract. Products like imatinib mesylate, sunitinib, and regorafenib offer precision action against aberrant KIT and PDGFRA gene...

0 Comentários 0 Compartilhamentos 751 Visualizações 0 Anterior